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Assessing Plasmodium falciparum 
transmission in mosquito-feeding assays using 
quantitative PCR
Claire Y. T. Wang1,2, James S. McCarthy3, Will J. Stone4, Teun Bousema4, Katharine A. Collins3*†  
and Seweryn Bialasiewicz1,2†
Abstract 
Background: Evaluating the efficacy of transmission-blocking interventions relies on mosquito-feeding assays, with 
transmission typically assessed by microscopic identification of oocysts in mosquito midguts; however, microscopy 
has limited throughput, sensitivity and specificity. Where low prevalence and intensity mosquito infections occur, as 
observed during controlled human malaria infection studies or natural transmission, a reliable method for detection 
and quantification of low-level midgut infection is required. Here, a semi-automated, Taqman quantitative PCR (qPCR) 
assay sufficiently sensitive to detect a single-oocyst midgut infection is described.
Results: Extraction of genomic DNA from Anopheles stephensi midguts using a semi-automated extraction process 
was shown to have equivalent extraction efficiency to manual DNA extraction. An 18S Plasmodium falciparum qPCR 
assay was adapted for quantitative detection of P. falciparum midgut oocyst infection using synthetic DNA standards. 
The assay was validated for sensitivity and specificity, and the limit of detection was 0.7 genomes/µL (95% CI 0.4–1.6 
genomes/µL). All microscopy-confirmed oocyst infected midgut samples were detected by qPCR, including all single-
oocyst positive midguts. The genome number per oocyst was assessed 8–9 days after feeding assay using both qPCR 
and droplet digital PCR and was 3722 (IQR: 2951–5453) and 3490 (IQR: 2720–4182), respectively.
Conclusions: This semi-automated qPCR method enables accurate detection of low-level P. falciparum oocyst infec-
tions in mosquito midguts, and may improve the sensitivity, specificity and throughput of assays used to evaluate 
candidate transmission-blocking interventions.
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Background
Despite recent progress with malaria control, it remains a 
significant global health problem, with an estimated 212 
million new cases of malaria occurring in 2015 [1]. Pro-
gress to date has been achieved by increasing access to 
effective anti-malarial treatment and reducing transmis-
sion using vector control measures [2]; however, the effi-
cacy of these interventions is threatened by development 
of drug [3–5] and insecticide [6, 7] resistance. To main-
tain progress and achieve elimination, existing malaria 
control measures may need to be supplemented with 
novel tools. Drugs and vaccines that specifically aim to 
prevent transmission through mosquito vectors may be 
particularly effective in reducing malaria incidence and 
the onward transmission of resistant malaria parasites 
[8].
The efficacy of transmission-blocking drugs and vac-
cines is normally evaluated in mosquito-feeding assays 
that allow mosquitoes to feed on either in vitro cultured 
gametocytes [9, 10], or gametocytaemic blood from 
naturally or experimentally infected volunteers [11, 12]. 
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Transmission of malaria to mosquitoes is then assessed 
by detection of either oocysts within the mosquito mid-
gut or sporozoites in the salivary glands, typically using 
microscopy. Although microscopy is the gold-standard 
method for detecting mosquito infection, it has a num-
ber of limitations. The technique is labour-intensive and 
therefore difficult to scale up for large studies [13], it is 
technically demanding, and it can be difficult to distin-
guish oocysts from other artefacts—particularly with 
low-level infections [14]—making it difficult to accurately 
confirm or exclude single-oocyst infection.
In contrast to the highly infected mosquitoes gener-
ated in laboratory mosquito-feeding assays, the intensity 
of mosquito infection (midgut oocyst numbers) is typi-
cally low in mosquito feeding experiments on naturally 
or experimentally infected subjects, due to the low game-
tocyte densities present in the mosquitoes blood meal 
[15–18]. To accurately evaluate the in vivo transmission 
of malaria in such settings, a large number of mosquitoes 
must be used in feeding assays, and thus, a high-through-
put method capable of sensitive and specific detection of 
midgut-oocyst infection is needed [19, 20].
Methods have previously been developed to overcome 
the limitations of microscopy and include ELISA to 
detect the circumsporozoite protein in mosquito lysates 
(CSP-ELISA) [21–23], bioluminescence assays to detect 
transgenic parasites expressing GFP or firefly luciferase 
[13, 24, 25], and molecular detection of Plasmodium 
DNA [23, 26, 27]. While CSP-ELISA has been reported to 
be robust and cost effective, variations in sensitivity and 
specificity have been reported and at present these assays 
are not truly quantitative [23, 28, 29]. Bioluminescence 
assays have been particularly useful for increasing the 
throughput of experiments where transgenic parasites 
can be used; but these assays cannot be used to evaluate 
transmission in natural infections or during controlled 
human malaria infection (CHMI) studies involving wild 
type parasites. Various PCR-based methods have been 
successfully used for detection of mosquito infection in 
different settings [23, 26, 27]; however, while these assays 
offer increased sensitivity of detection, they are either 
not fully quantitative, or rely on signal detection by non-
specific SYBR-green fluorescent dyes. Taqman hydrolysis 
probes offer an alternative to SYBR-based real-time PCR, 
and superior specificity and accuracy due to the addi-
tional requirement of probe homology to the specific tar-
get in order to generate a positive signal [30, 31]. Taqman 
hydrolysis probes have been widely adopted for quanti-
tative PCR (qPCR) assays targeting the Plasmodium 18S 
ribosomal RNA gene (hereafter referred to as 18S qPCR) 
to monitor the development of blood-stage infection 
during CHMI studies [16, 18, 31–33]. Such assays are 
routinely able to quantify parasitaemia at levels ~ 100 fold 
lower than expert thick-film microscopy [34–36]. In this 
study, an existing 18S Taqman qPCR assay was adapted 
to assess the prevalence of P. falciparum oocyst infection 
in mosquito midguts. Synthetic plasmid DNA standards 
were developed and validated to allow quantification of 
parasite genomes in oocyst-infected midguts, assay con-
trols were used to ensure reproducibility of assay perfor-
mance, and the assay was adapted to a semi-automated 
process to allow increased throughput. In addition, the 
ability of the assay to detect microscopy-confirmed sin-
gle-oocyst positive midguts was evaluated, and quanti-
fication of genome copies by 18S qPCR was compared 
with absolute quantification by droplet digital PCR 
(ddPCR) [37] to ensure confidence in estimating midgut 
parasite burden.
Methods
Mosquito rearing
Anopheles stephensi mosquitoes (Sind-Kasur Nijmegen 
strain [38]) were reared at 27  °C and ~ 70–80% relative 
humidity (RH) on a 12 h day/night cycle and were fed on 
8% sucrose with para-aminobenzoic acid (PABA). Mos-
quitoes between 3 and 5 days post emergence were used 
for negative controls or were fed on gametocytaemic 
blood.
Preparation of mosquito midgut samples for assay 
validation
For assay optimization negative control midguts were 
collected from non-blood fed An. stephensi mosqui-
toes, added to lysis buffer as detailed below, and stored 
at − 20 °C until DNA extraction (n = 124). Twenty-three 
infected midguts from An. stephensi mosquitoes (Rad-
boud University Medical Centre) were used as positive 
control material. Midguts were collected from mosqui-
toes 7 days after feeding and were prepared as previously 
described [23]. They were stained with 1% mercuro-
chrome, examined by microscopy, and oocyst numbers in 
each midgut recorded. After examination by microscopy, 
slides were flooded with PBS to allow easy removal of 
coverslips, and excess mercurochrome was removed by 
dragging the midgut gently through a clean PBS droplet. 
Midguts were stored in 40 µL PBS at − 80 °C.
Preparation of mosquito midgut samples from a CHMI 
study
Mosquitoes were fed on gametocytaemic blood from vol-
unteers enrolled in a CHMI transmission study via either 
direct skin feeding or membrane feeding assays [18]. 
Mosquitoes were dissected for evaluation of oocysts on 
day 8 or 9 after feeding assay. Midguts were collected in 
180  µL of DNA Tissue Lysis buffer (Roche Diagnostics, 
Australia) for PCR analysis, or were stained with 0.5% 
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mercurochrome for visualization of oocysts by micros-
copy prior to collection in lysis buffer and PCR analysis.
Preparation of mosquito midguts for non‑oocyst parasite 
DNA detection
Two concentrations of parasite infected blood meal were 
prepared from a mixed parasite culture (predominantly 
gametocytes): 1 gametocyte/µL, which is the average 
gametocyte density in volunteers during a CHMI trans-
mission study, and 1000 gametocytes/µL, which is greater 
than the peak parasitaemia in CHMI transmission study 
volunteers. These parasite-infected blood-meals were 
heat-inactivated for 20  min at 42  °C prior to feeding to 
ensure parasites were no longer viable, and therefore 
unable to develop into oocysts [39, 40]. Two batches of 
An. stephensi mosquitoes were fed with the two different 
concentrations of parasites, and samples of mosquitoes 
(n = 7–10) were dissected from each batch at time points 
between day 1 and day 10 post-infection. Midguts were 
stored in 180 µL Roche lysis buffer at − 80 °C until DNA 
extraction.
Manual DNA extraction
Mosquito midguts were stored in 300  µL ATL buffer 
(QIAGEN, Australia), spiked with a known amount of 
whole Equine Herpesvirus (EHV) and stored at − 20  °C 
until DNA extraction. Prior to extraction, samples were 
homogenized with acid-washed glass beads (425–
600 μm/Cat# G4649-500G, Sigma-Aldrich) on the Tissue 
Lyser (QIAGEN, Australia) at 30 oscillation/s for 2 min. 
Supernatant was collected and 40  µL of proteinase K 
was added and the sample incubated at 56 °C overnight. 
Nucleic acid extraction was performed the next day using 
the DNeasy Tissue & Blood kit (QIAGEN, Australia) fol-
lowing the manufacturer’s protocol. Total nucleic acid 
was eluted into 50  µL and stored at − 80  °C until PCR 
was performed.
Semi‑automated DNA extraction
Mosquito midguts were stored in 180  µL DNA Tissue 
Lysis buffer (Roche Diagnostics, Australia) spiked with a 
known amount of EHV. 20 µL of Proteinase K was added 
to the lysis mixture, followed by incubation overnight at 
56 °C. Total nucleic acid was extracted from the midgut 
lysates using the DNA and Viral NA Small Volume Kit on 
the MagNA Pure 96 instrument (Roche Diagnostics, Aus-
tralia) following the manufacturer’s protocol (DNATis-
sue SV2.0). Total nucleic acid was eluted into 100 µL and 
stored at − 80 °C until PCR was performed.
RPS7 and EHV PCR assays for extraction quality control
A Taqman hydrolysis probe PCR assay targeting the 
ribosomal RNA protein S7 (RPS7) gene [41] of An. ste-
phensi (Genbank Accession No. AF539918) was designed 
(Table 1). In silico analysis of the PCR primers and probes 
using BLASTn (NCBI) showed high specificity to An. ste-
phensi, with some sequence homology to ortholog genes 
in several other mosquito species (e.g.: Anopheles gam-
biae, Aedes aegypti). No predicted primer interactions 
leading to PCR amplification in non-mosquito templates 
were observed. The RPS7 assay was analysed on a 1:10 
dilution series of whole mosquito DNA extracts, with the 
expected logarithmic progression of dilution series (from 
Cp 19 to 35) being observed (see Additional file 1).
A second PCR assay (Table  1) targeting the spiked 
EHV was run in conjunction with the RPS7 assay to 
monitor extraction efficiency and inhibition of PCR 
[42]. The QuantiNova Probe PCR Kit (Qiagen, Aus-
tralia) was used for all midgut testing. Each 10 µL PCR 
reaction consisted of 0.4  µM of each primer, 0.2  µM 
of probe, Rox reference dye (1:200) and 4  µL of tem-
plate DNA. Amplification was performed on a ViiA7 
Real-Time PCR System (Life Technologies, Australia) 
in a 384-well format, with the following cycling con-
ditions: 95  °C heat activation for 2  min, 45 fast cycles 
of 95  °C for 5  s and 60  °C for 5  s. Sample quality and 
Table 1 Primer and probe sequences used in this study
Oligonucleotide names Sequence Target References
PerFal 5′-CTT TTG AGA GGT TTT GTT ACT TTG AGTAA-3′ P. falciparum 18S rRNA gene [31]
5′-TAT TCC ATG CTG TAG TAT TCA AAC ACA-3′
5-FAM-TGT TCA TAA CAG ACG GGT AGT CAT GAT TGA GTTCA-BHQ1′
RPS7 5′-TGG AAA TGA ACT CGG ATC TGAAG-3′ An. stephensi rRNA protein S7 gene 
(RPS7)
[41]
5′-CCT TCT TGT TGT TGA ACT CGA CCT -3′ This study
5′-HEX-CAG CTG CGT GAT CTG TAC ATC ACC CGCGC BHQ1′ This study
EHV 5′-GAT GAC ACT AGC GAC TTC GA-3′ Equine Herpesvirus [42]
5′-CAG GGC AGA AAC CAT AGA CA-3′
5′-QUASAR670 -TTT CGC GTG CCT CCT CCA G-BHQ1′
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DNA extraction efficiency was considered acceptable 
if the EHV and RPS7 PCR crossing point (Cp) values 
fell within 2 standard deviations (SD) of the mean Cp 
within each extraction/PCR run. These limits of accept-
ability (mean Cp ± 2 SD) were based on recommenda-
tions by the minimum information for publication of 
quantitative real-time PCR experiments (MIQE) guide-
lines and Burd [43, 44] to account for variations within 
95% confidence interval for evaluating qPCR assay 
variances.
For comparison of DNA extraction methods total 
nucleic acid was extracted from uninfected midguts 
using the manual method (n = 62) or the semi-auto-
mated method (n = 62) and analysed using the RPS7 
and EHV PCR assays. Cp values for both PCR assays 
obtained from the manual extraction method were 
adjusted (1  Cp) based on DNA template doubling at 
each PCR cycle [45] to reflect the 1:2 difference in elu-
tion volume before data analysis.
18S qPCR assay
Plasmodium falciparum parasite quantification was 
undertaken using a previously published Taqman qPCR 
assay targeting the 18S rRNA gene (Table  1) [31]. In 
silico analysis of 18S qPCR oligonucleotide specificity 
using the NCBI and PlasmoDB [46] databases showed 
100% identity to the P. falciparum 3D7 18S rRNA 
gene, and no predicted cross-reactivity with any other 
human Plasmodium species. Further characterization 
of the assay was performed based on the MIQE guide-
lines [44], including limit of detection (LOD) using 
synthetic plasmid dilution series, as well as specific-
ity and repeatability (intra-assay variability). The syn-
thetic DNA standards (syn18S DNA) consisted of the 
18S qPCR target cloned into a pMA-T plasmid back-
bone (Thermo Fisher Scientific, Australia) and serially 
diluted in uninfected whole blood nucleic acid extract 
to give final concentrations of 7.2 × 104 to 0.1 DNA cop-
ies/µL. Six replicates of each standard were analysed 
with the 18S qPCR assay three times on separate days 
to determine the assay analytical sensitivity and repeat-
ability [43]. Six uninfected human whole blood extracts 
were included as negative controls in each qPCR run. 
Additional uninfected blood extracts (n = 54) from vol-
unteers were analysed on 18S qPCR assay to determine 
assay specificity.
Quantification of 18S rDNA copies in midguts was 
achieved using a standard curve generated from the 
syn18S DNA dilutions. Copy numbers were converted 
to genome numbers based on the alignment of qPCR 
assay to NCBI reference P. falciparum 3D7 genome in 
Geneious software (Geneious version 10.2, Biomatters 
[47]) and the number of PCR assay binding sites per 
genome was determined to be 3.
18S ddPCR
The 18S qPCR assay was adapted to the droplet digi-
tal PCR format. Triplicate syn18S DNA serial dilutions 
and 14 microscopy-confirmed oocyst-positive midguts 
(oocyst number: 1–3) from a CHMI transmission study 
were extracted on the MagNA Pure 96 and analysed in 
duplicate on the QX-200 ddPCR system (BioRad, Aus-
tralia) to obtain absolute quantification of parasite 
genomes. The ddPCR reactions were prepared using 
ddPCR Supermix for Probes (no dUTP) following man-
ufacturer’s protocol. Each 20  µL ddPCR reaction con-
tained 0.9  µM of each 18S primer, 0.25  µM of Taqman 
probe, 1 µL of HAEIII restriction enzyme mix (5 U/µL) 
(Promega, Australia), and 5 µL of DNA template. Ampli-
fication was performed on a C1000 Touch thermal cycler 
(BioRad, Australia) following the conditions of 95 °C for 
10 min, 40 cycles of 94 °C for 30 s and 60 °C for 60 s, with 
final step of 98 °C for 10 min and 4 °C forever. Genome 
quantification was determined using the QuantaSoft 
analysis software (Bio-Rad, Australia). Reactions contain-
ing uninfected human whole blood or midgut nucleic 
acid extracts were used to determine the negative ampli-
tude threshold for the synthetic controls and parasite 
positive midguts, respectively. Droplet count per sample 
ranged from 17,547 to 21,044, with a mean fluorescence 
amplitude of 7816 for positive and 702 for negative sam-
ples (see Additional file 2).
Statistical analysis
Statistical analysis was performed using GraphPad Prism 
(ver. 7.03) or STATA (version 14.2, StataCorp, College 
Station, Texas). The relative extraction efficiencies of the 
manual and automated methods were compared using 
the Cp values generated from EHV and RPS7 PCR assays 
and Student’s t test to determine if two methods pro-
duced comparable nucleic acid yields. 18S qPCR assay 
LOD was estimated by probit analysis and defined as the 
concentration at which 95% of the samples test positive 
(SPSS ver. 25, SPSS, Inc, Chicago, IL).
Results
Validation of 18S qPCR for genome quantification
To quantify the number of genomes detected in the mos-
quito midguts using the 18S qPCR assay, a standard curve 
was generated using synthetic plasmid DNA. From three 
independent PCR reactions assay efficiency was consist-
ently greater than 90% (range 90–99%). The  LOD95% was 
determined to be 2.1 DNA copies/µL (95% CI 1.3–4.7 
copies/µL) which translates to 0.7 genomes/µL. False-
positives were not observed in the negative controls of 
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the three PCR runs (see Additional file  3) or the addi-
tional 54 uninfected human blood extracts, demonstrat-
ing assay specificity of 100%. Precision was assessed using 
the Cp values of amplification curves from each dilution 
to derive standard deviations (SD) and % CV. To ensure a 
robust estimation of precision, Cp values greater than 40 
(n = 2; Cp 41.2—1.4 copies/µL and Cp 43 0.7 copies/µL) 
were excluded from the analysis. The mean SD and   % 
CV from the three PCR runs was 0.69 (pooled SD across 
standards) and 2.07 respectively, showing good repeat-
ability (see Additional file 3).
Evaluation of midgut DNA extraction methods
The RPS7 PCR assay was developed to evaluate the 
efficiency of DNA extraction from midgut tissue. Pre-
liminary evaluation using DNA extracts from whole 
mosquitoes (n = 5) or midguts (n = 15), resulted in ampli-
fication of the appropriate size PCR product, with sub-
sequent DNA sequence analysis confirming the correct 
amplicon identity. Mean Cp values for whole mosquitoes 
and isolated midguts were 19.2 and 23.6, respectively 
(midgut Cp range 22–27, due to variation in midgut tis-
sue size) (see Additional file  4). No amplification was 
observed in uninfected human whole blood (n = 12), or 
in nucleic acid extracted from cultured P. falciparum-
infected RBCs (n = 12) demonstrating specificity.
The RPS7 and EHV PCR assays [42] were used to 
evaluate the efficiency of manual DNA extraction using 
midguts from mosquitoes fed on cultured P. falciparum 
gametocytes and collected in EHV-spiked buffer (n = 96). 
All extracts were positive in both PCR assays with aver-
age Cp values of 24.75 (95% CI 24.68–24.82) for EHV, 
and 22.85 (95% CI 22.68–23.02) for RPS7 (Table 2). The 
EHV Cp values from the midgut extracts were equivalent 
to those obtained from EHV-spiked PBS (Cp 24–25) indi-
cating no PCR inhibition in midgut tissue extracts. RPS7 
Cp values showed higher variability due to the varied size 
of the mosquitoes and their midguts, but the variation 
was small (CV < 5%). Plasmodium DNA could also be 
detected using this extraction method with 100% agree-
ment between 18S qPCR and microscopy results. Eleven 
microscopy-confirmed P. falciparum oocyst-positive 
midguts (oocyst number ranging 1–4) were evaluated; all 
had EHV and RPS7 Cp values within the acceptable QC 
range (mean Cp ± 2 SD [43]) (Table 2) and all had P. falci-
parum DNA detected by 18S qPCR.
To enable large scale processing (> 2000 midguts) dur-
ing CHMI transmission studies, a semi-automated DNA 
extraction method was evaluated and efficiency was 
compared to manual method using the RPS7 and EHV 
PCR assays. Cp values obtained for the two PCR assays 
were not significantly different (EHV p = 0.56 and RPS7 
p = 0.38) comparing the two DNA extraction methods by 
Student’s t test (Fig.  1). Therefore, the semi-automated 
method showed equivalent performance to the manual 
method and is suitable for large scale processing.
The semi-automated extraction method also allowed 
the detection of low-intensity midgut oocyst infec-
tions. 12 microscopy-confirmed oocyst-positive midguts 
(oocyst number: 1–9) were evaluated and all were posi-
tive by 18S qPCR assay, including detection of all single-
oocyst positive midguts (n = 7; see Additional file 5).
Further evaluation using 2344 midguts collected dur-
ing a CHMI transmission study [18] demonstrated that 
the RPS7 PCR assay can be used to monitor midgut 
Table 2 Manual extraction efficiency evaluated using EHV 
and RPS7 markers
Mean Cp and 95% CI values displayed for the EHV and RPS7 PCR analysis of An. 
stephensi mosquito midguts fed on gametocyte culture with unknown infection 
status (n = 96) or with microscopy-confirmed P. falciparum oocysts (n = 11/
oocyst numbers range 1–4). The 11 microscopy-positive midguts were also 
confirmed positive by 18S qPCR
PCR target Midguts from mosquitoes 
fed on gametocyte culture
Mean Cp (95% CI)
Midguts with microscopy‑
confirmed P. falciparum 
oocysts
Mean Cp (95% CI)
EHV 24.75
(24.68–24.82)
24.14
(23.68–24.61)
RPS7 22.85
(22.68–23.02)
23.03
(22.0–24.07)
Fig. 1 Comparison of DNA extraction efficiency using manual and 
semi-automated processes. DNA was extracted from two batches 
of 62 midguts using either the manual or semi-automated methods 
with efficiency compared by measuring the RPS7 and EHV DNA. The 
lines indicate the group mean and the groups were compared by 
Student’s t test (p = 0.38 and p = 0.56 for RPS7 and EHV, respectively)
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collection and DNA extraction quality during large scale 
processing. Genomic DNA was extracted using the semi-
automated method and the RPS7 mean Cp was 23.16 
(95% CI 23.13–23.19). Using the acceptability criteria for 
the RPS7 assay of mean Cp ± 2 SD, 1.5% (35/2344) of the 
midguts fell outside the QC range suggesting partial loss 
of tissue or incomplete tissue lysis.
Specificity of the 18S qPCR assay for oocyst detection
18S qPCR performed on midguts 7–10  days after mos-
quito feeding assay was shown to be specific for develop-
ing oocysts, and residual asexual parasite or gametocyte 
DNA from the blood-meal was not detected. This was 
determined by evaluating midguts from mosquitoes 
fed on heat-inactivated gametocytes (1 or 1000  game-
tocytes/µL). On day 1 post-feeding, P. falciparum DNA 
was detected in all mosquito midguts (Table 3) with aver-
age 18S Cp values of 38.5 and 33.1 for mosquitoes fed on 
the 1 and 1000 gametocytes/µL culture, respectively. By 
day 2, 18S qPCR was negative in all mosquitoes fed on 
the 1  gametocyte/µL blood meal and in 9/10 mosqui-
toes (90%) fed on the 1000 gametocytes/μL blood meal. 
The 18S qPCR was negative in all mosquitoes evaluated 
between day 3 and 10 indicating residual non-oocyst P. 
falciparum DNA is not detected from 3 days after mos-
quito feeding.
Midgut genome quantification using ddPCR and qPCR
High concordance between ddPCR and qPCR quantifica-
tion was observed when using both syn18S DNA plasmid 
standards and microscopy-confirmed oocyst-positive 
midguts from a CHMI transmission study [18]. A uni-
versal positive/negative threshold was set at a fluores-
cence amplitude of 1853 using uninfected human blood 
nucleic acid extracts or uninfected midguts (Fig. 2a + c). 
Using the syn18S DNA plasmid standards, the ddPCR 
assay was unable to accurately quantify target copy num-
bers above 7.2 × 103 DNA copies/µL due to the reaction 
not generating sufficient numbers of negative droplets 
to perform the Poisson distribution calculations (i.e.: the 
saturation point of the assay) (Fig. 2a). All other syn18S 
DNA standards including the lowest dilution (0.72  DNA 
copies/µL) were detected by ddPCR, with quantification 
of copy numbers closely matching the predicted qPCR 
syn18S DNA copy numbers (Fig. 2b and Table 4). 
ddPCR using midguts produced more variable fluo-
rescence values with less clear demarcation between 
positive and negative droplets compared to ddPCR using 
the syn18S templates (Fig. 2c). However, the 18S ddPCR 
assay was able to detect parasite genomes in all micros-
copy-confirmed oocyst-positive midguts (oocyst num-
bers ranging from 1 to 3). There was no difference in the 
number of genomes per oocyst calculated using ddPCR 
compared to qPCR (p = 0.43; Fig.  2d, see Additional 
file 6), with the median genome number per oocyst esti-
mated to be 3490 (IQR: 2720–4182) by ddPCR and 3722 
(IQR: 2951–5453) by qPCR.
Discussion
This study describes the development and validation of 
a higher throughput PCR based method for accurately 
detecting low-level midgut oocyst infections with no 
false positives. The assay is sufficiently sensitive to detect 
midgut infection with just a single oocyst, and it does 
not detect P. falciparum DNA in mosquito midguts from 
3  days after a blood meal is taken unless oocyst infec-
tion has been established. Furthermore, oocyst para-
site genomes can be quantified, and the values obtained 
by qPCR were validated by absolute quantification with 
droplet digital PCR.
Current methods to evaluate efficacy of transmission 
to mosquitoes include microscopy, CSP-ELISA, biolumi-
nescence assays and PCR. However, each method suffers 
limitations including a lack of assay sensitivity and speci-
ficity, low-throughput, non-quantitative outputs [22, 24, 
28, 48, 49] or the requirement for use of transgenic para-
sites [24]. Here a semi-automated qPCR-based method 
with a Taqman hydrolysis probe was used for increased 
assay specificity and sensitivity, to allow objective quan-
tification of parasite genomes, and to enable increased 
throughput for large-scale transmission studies.
To use PCR for evaluating transmission to mosquitoes, 
appropriate control assays are required to ensure variabil-
ity in sample quality, extraction efficiency, or PCR inhibi-
tion do not occur [43]. In this study, two quality control 
PCR assays were used, one to monitor DNA extraction 
efficiency (EHV) and the other to monitor midgut collec-
tion and extraction quality (RPS7). The Anopheles RPS7 
assay was specifically designed to ensure the presence of 
Table 3 Detection of  non-oocyst P. falciparum DNA 
in mosquito midguts after a blood meal
Days 
post‑
infection
1 parasite/µL blood meal 
(18S positive/total)
1000 parasites/µL blood 
meal (18S positive/total)
D1 10/10 (mean Cp 38.5; 
SD = 2.4)
9/9 (mean Cp 33.1; SD = 1.0)
D2 0/7 1/10 (Cp 38.4)
D3 0/10 0/10
D6 0/10 0/10
D7 0/10 0/10
D8 0/10 0/10
D9 0/10 0/10
D10 0/10 0/10
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Fig. 2 Droplet digital PCR for oocyst genome quantification. a One-dimensional scatter plots showing 18S ddPCR assay on positive (syn18s 
standards from 7.2 × 104 to 0.72 copies/µL) and negative human blood (“HGD”) extracts. Clear demarcation between positive and negative 
partitions is shown. Uninfected human blood extract reaction was used to determine a universal positive/negative threshold set at 1853. b 
Quantification of syn18s standards using ddPCR in triplicate (black circles indicate the median of each run with error bars showing 95% CI) 
compared to the predicted qPCR value (grey line). c One-dimensional scatter plots showing 18S ddPCR assay on 14 oocyst-positive midguts, with 
positive and negative partitions. Uninfected mosquito midguts (“Neg”) were used to determine a universal positive/negative threshold set at 
1853. d Quantification of genomes per oocyst for the14 microscopy-confirmed oocyst-positive midguts using 18S qPCR and 18S ddPCR. Box plots 
indicate the median and whiskers show the minimum and maximum responses. Groups compared using Wilcoxon matched-pairs signed rank test 
(p = 0.43)
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midgut tissue without partial sample loss, and to confirm 
complete lysis of the tissue during extraction. Variation is 
expected in the Cp values obtained using the RPS7 assay 
due to the varying size of the midgut tissue in the mos-
quitoes being evaluated. Analysis of 2344 midguts from 
a CHMI study enabled us to assess the expected range 
in midgut tissue size and resulting RPS7 Cp values, and 
ensure natural variation falls within our QC acceptabil-
ity range (mean Cp ± 2 SD), and values falling outside the 
QC range would indicate a failure in tissue sampling or 
processing. These QC assays used a relative QC accept-
ability range (mean Cp ± 2SD) instead of an absolute Cp 
value range, allowing the protocol to be easily adapted 
to new settings where the mosquito colony, age, size, or 
rearing protocols may vary causing shifts in the QC indi-
cators. These quality control assays were also used to 
compare the efficiency of DNA extraction using manual 
and semi-automated methods. The semi-automated 
extraction method resulted in an equivalent yield of PCR 
target to the manual extraction approach, but with con-
siderably increased throughput.
The 18S qPCR assay used in this study has been pre-
viously described [31] and validated against FACS 
quantified cultured parasites in whole blood. To quan-
tify genomes within oocysts, synthetic DNA standards 
were generated using a plasmid containing a single copy 
of the assay target. The analytical sensitivity of the assay 
was determined according to stringent guidelines [43, 
44], resulting in a LOD of 2.1 DNA copies/µL (or 0.7 
genomes/µL). Using the synthetic DNA standards, the 
18S qPCR assay was able to quantify parasite genomes 
in all known oocyst-positive samples. Single-oocyst 
positive midguts were consistency detected across mul-
tiple extraction methods and PCR platforms, thereby 
demonstrating the assay’s potential utility in settings 
where low-prevalence and low-intensity infections are 
expected, such as CHMI transmission studies [18] and 
natural transmission [17, 50]. Residual non-oocyst P. 
falciparum DNA did not persist for more than 2  days 
after the mosquito blood meal and, therefore, does not 
interfere with oocyst detection, in accordance with pre-
vious observations [27].
Limited information exists on the impact of mercu-
rochrome on DNA recovery and its use in PCR. This 
study, in agreement with a previous report [51], demon-
strates the capacity for successful retrieval and detec-
tion of parasite DNA from mercurochrome-stained 
midguts. However, the impact of mercurochrome, a 
potential intercalating agent [52], on DNA quality and 
integrity was not specifically assessed in these studies 
and may require further investigation.
Quantification of genome numbers per oocyst were 
equivalent using the 18S qPCR and 18S ddPCR assays 
with median genomes per oocyst being 3722 and 3490, 
respectively. Two recent studies using ddPCR for detec-
tion of malaria in culture and Plasmodium infected 
subjects also reported good agreement in parasite esti-
mates between ddPCR and qPCR, but with improved 
sensitivity and precision observed using ddPCR, par-
ticularly in low-density infections [53, 54]. An addi-
tional advantage of ddPCR is the ability to accurately 
quantify parasites without the need for external stand-
ards, making it easier to compare data between labora-
tories [53]. However, despite these potential benefits, 
the close agreement between the two PCR technologies 
found in this study shows that qPCR can still be used in 
field studies and other situations where ddPCR instru-
ments are not available.
In the samples evaluated here, genome numbers per 
oocyst were consistent irrespective of oocyst number 
per midgut suggesting that quantification of genome 
numbers could be used to enumerate oocysts. However, 
Table 4 18S ddPCR with synthetic DNA standards
a  qPCR Cp values for the synthetic standards are shown as means (n = 18). No quantification results produced for qPCR as the synthetic standards were used to 
produce standard curve
b  syn18s DNA predicted copies/µL as calculated based on Qubit reading
c  Triplicate ddPCR reaction data for each dilution is shown as total and individual amounts, where the total amount was calculated based on the triplicate reaction 
data being treated as one larger sample
d  ddPCR 95% confidence intervals (CI) are shown based on the total data calculations
qPCR ddPCR (DNA copies/µL)
qPCR  Cpa Predicted DNA copies/µLb Totalc Individual  meanc (95%  CId)
syn18s-5 19.5 72,100 Saturated Saturated (n/a)
syn18s-6 22.7 7210 6176 6198.7 (6790–5600)
syn18s-7 26.1 721 714 717.3 (804–628)
syn18s-8 29.4 72 72 72.4 (83.2–61.6)
syn18s-9 33.3 7.2 6.6 6.7 (8.1–8.3)
syn18s-10 36.7 0.72 0.84 0.9 (1.5–0.4)
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only low intensity infections (oocyst number ≤ 3) were 
assayed, thus further evaluation with a greater range of 
oocyst numbers would be required to fully investigate 
the relationship between parasite genomes and oocyst 
numbers. It is possible that this relationship may be non-
linear, and with higher infection intensity (more oocysts) 
lower numbers of genomes may be present per oocyst 
[24]. This qPCR assay may therefore allow for a more 
accurate estimation of mosquito infectivity by quantify-
ing numbers of infectious sporozoites instead of numbers 
of oocysts, which may be more relevant when assessing 
the potential for onward transmission [55]. Although the 
PCR based assay developed here is sensitive, provides 
robust and accurate estimation of parasite infections in 
mosquitoes, and has increased throughput due to the use 
of semi-automated DNA extraction, at present it still uses 
dissected midguts. Dissection of the mosquitoes limits a 
further increase in throughput, but it may be possible to 
adapt this method to allow processing of whole mosqui-
toes [23], or pools of whole mosquitoes and to assess sali-
vary gland sporozoite infection intensity. The RPS7 and 
EHV control assays will facilitate the future development 
and evaluation of such assays.
Conclusions
A sensitive method for detecting oocyst-specific P. fal-
ciparum DNA in mosquito midguts was successfully 
developed with capacity for increased specificity and 
throughput. QC criteria were established for sample 
processing and applied to quantify low-level oocyst 
infections in mosquito midguts. The emergent ddPCR 
technology was used to verify results and demonstrate its 
utility in future CHMI studies. This assay shows promise 
as a tool to evaluate transmission-blocking interventions 
both in experimental CHMI transmission studies and in 
malaria-endemic settings.
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